209 related articles for article (PubMed ID: 33569387)
1. Antisynthetase Syndrome-Associated Interstitial Lung Disease: Monitoring of Immunosuppressive Treatment Effects by Chest Computed Tomography.
Korsten P; Rademacher JG; Riedel L; Schnitzler EM; Olgemöller U; Seitz CS; Schmidt J; Larsen J; Vasko R
Front Med (Lausanne); 2020; 7():609595. PubMed ID: 33569387
[No Abstract] [Full Text] [Related]
2. Antisynthetase syndrome-related interstitial lung disease (ASyS-ILD): longitudinal imaging findings.
Wu W; Collins BF; Gardner GC; Hippe DS; Ho LA; Raghu G; Pipavath SNJ
Eur Radiol; 2023 Jul; 33(7):4746-4757. PubMed ID: 36786906
[TBL] [Abstract][Full Text] [Related]
3. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.
Barratt SL; Adamali HH; Cotton C; Mulhearn B; Iftikhar H; Pauling JD; Spencer L; Adamali HI; Gunawardena H
BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33419741
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
[TBL] [Abstract][Full Text] [Related]
5. A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.
Patel P; Marinock JM; Ajmeri A; Brent LH
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674039
[TBL] [Abstract][Full Text] [Related]
6. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
[TBL] [Abstract][Full Text] [Related]
7. Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective Study.
Langlois V; Gillibert A; Uzunhan Y; Chabi ML; Hachulla E; Landon-Cardinal O; Mariampillai K; Champtiaux N; Nunes H; Benveniste O; Hervier B
J Rheumatol; 2020 Nov; 47(11):1678-1686. PubMed ID: 32173654
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Involvement in the Antisynthetase Syndrome: A Comparative Cross-sectional Study.
Andersson H; Aaløkken TM; Günther A; Mynarek GK; Garen T; Lund MB; Molberg Ø
J Rheumatol; 2016 Jun; 43(6):1107-13. PubMed ID: 27036381
[TBL] [Abstract][Full Text] [Related]
9. Antisynthetase Syndrome With Predominant Pulmonary Involvement: A Case Report.
Lima Corrêa de Araújo B; Victor DR; Farias Fontes HM; Caminha Mendes Gomes RM; Lima Corrêa de Araújo L
Cureus; 2023 Aug; 15(8):e43966. PubMed ID: 37746430
[TBL] [Abstract][Full Text] [Related]
10. Review of Pulmonary Manifestations in Antisynthetase Syndrome.
Ghanbar MI; Danoff SK
Semin Respir Crit Care Med; 2024 Jun; 45(3):365-385. PubMed ID: 38710221
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in connective tissue disease-associated interstitial lung disease.
Duarte AC; Cordeiro A; Fernandes BM; Bernardes M; Martins P; Cordeiro I; Santiago T; Seixas MI; Ribeiro AR; Santos MJ
Clin Rheumatol; 2019 Jul; 38(7):2001-2009. PubMed ID: 31016581
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of patients with antisynthetase syndrome and interstitial pulmonary disease].
Li W; Li J; Xie WM; Ren YH; Dai HP
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1861-1865. PubMed ID: 32575928
[No Abstract] [Full Text] [Related]
13. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome.
Narváez J; Cañadillas E; Castellví I; Alegre JJ; Vincens-Zygmunt V; Bermudo G; Vidal-Montal P; Molina Molina M; Nolla JM
Arthritis Res Ther; 2024 Jun; 26(1):122. PubMed ID: 38890654
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
Respir Med; 2020; 165():105920. PubMed ID: 32174452
[TBL] [Abstract][Full Text] [Related]
16. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
[TBL] [Abstract][Full Text] [Related]
17. Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion.
Liossis SC; Bounia CA
Front Med (Lausanne); 2022; 9():937561. PubMed ID: 35847798
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study.
Jensen ML; Løkke A; Hilberg O; Hyldgaard C; Bendstrup E; Tran D
Eur Clin Respir J; 2019; 6(1):1583516. PubMed ID: 30834073
[No Abstract] [Full Text] [Related]
19. The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.
Smits B; Goldacker S; Seneviratne S; Malphettes M; Longhurst H; Mohamed OE; Witt-Rautenberg C; Leeman L; Schwaneck E; Raymond I; Meghit K; Uhlmann A; Winterhalter C; van Montfrans J; Klima M; Workman S; Fieschi C; Lorenzo L; Boyle S; Onyango-Odera S; Price S; Schmalzing M; Aurillac V; Prasse A; Hartmann I; Meerburg JJ; Kemner-van de Corput M; Tiddens H; Grimbacher B; Kelleher P; Patel SY; Korganow AS; Viallard JF; Tony HP; Bethune C; Schulze-Koops H; Witte T; Huissoon A; Baxendale H; Grigoriadou S; Oksenhendler E; Burns SO; Warnatz K
J Allergy Clin Immunol; 2023 Aug; 152(2):528-537. PubMed ID: 36587851
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations and treatment of antisynthetase syndrome.
Marco JL; Collins BF
Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101503. PubMed ID: 32284267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
